
PHLDB3 inhibits the p53 protein to promote tumor growth.

Study estimates 27% of men avoided an unnecessary biopsy for prostate cancer when given an MRI scan first.

Top news of the day from across the health care landscape.

PGAM1 inhibitors sensitize tumors to lynparza (Olaparib) treatment.

Statins degrade mutated p53 proteins, offering future cancer treatment.

Poor long-term survival rates for pediatric patients with acute megakaryoblastic leukemia.

PAN-301-1 is a vaccine candidate to treat patients with persistent prostate cancer.

Top news of the week in oncology and cancer drug development.

Increased use of biosimilars could create sustainable care for multiple chronic diseases.

Utilization of biosimilars has the potential to overhaul cancer treatment.

Simeprevir was approved by the FDA in late 2013 for hepatitis C virus.

Specialty marketplace continues to thrive going forward.

Methotrexate and cyclophosphamide burn excessive dietary fat.

Aurintricarboxylic acid blocks the spread of glioblastoma.

Plant compound inhibits the metastasis of aggressive breast cancer in mice.

Markers identify patients who benefit from new and more aggressive prostate cancer treatments.

Small cell tumors respond differently to treatment.

Conflicts of interest among committee members who set hepatitis C treatment guidelines may influence decision-making.

Cancer screenings do not reduce the incidence of advanced tumors.

Top news of the day from across the health care landscape.

Physical activity can help overcome comorbidities associated with aromatase inhibitor treatment for breast cancer.

Post-breast cancer treatment with aromatase inhibitors may cause adverse events.

Antibody-based therapy may be a novel addition to immunotherapies for breast cancer, lung cancer, and colon cancer.

Cognitive impairment more prevalent in patients with HIV coinfection than in those with hepatitis C infection alone.

Top news of the day from across the health care landscape.

Top news of the week in oncology and cancer drug development.

A $450,000 research grant is targeting triple negative breast cancer and HER2-positive breast cancer.

Level of emotional distress after prostate cancer diagnosis increases likelihood of choosing surgery over active surveillance.

Cancer cells more prone to damage and death from high amounts of hydrogen peroxide.